Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Jade Biosciences, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 153
- +35 vs. Q1 2026
- Shares held
- 72.9M
- +26.2M (+56.0%) vs. Q1 2026
- Total value
- $1.62B
- +$962.6M (+146.6%) vs. Q1 2026
- New holders
- 51
- 61 more added
- Sold out
- 16
- 25 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameriprise Financial Inc | 107,053 | $2.38M | 0.00% | +107,053 | New |
| Sofinnova Investments, Inc. | 107,391 | $2.39M | 0.13% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 112,703 | $2.50M | 0.05% | −27,265−19.5% | Reduced |
| Quantinno Capital Management LP | 114,716 | $2.55M | 0.00% | +84,165+275.5% | Added |
| Morgan Stanley | 124,513 | $2.77M | 0.00% | +73,918+146.1% | Added |
| UBS Group AG | 127,577 | $2.83M | 0.00% | +62,555+96.2% | Added |
| Schroder Investment Management Group | 140,886 | $3.11M | 0.00% | +101,607+258.7% | Added |
| Opaleye Management Inc. | 145,000 | $3.22M | 0.29% | −282,608−66.1% | Reduced |
| Russell Investments Group, Ltd. | 163,084 | $3.62M | 0.00% | +55,488+51.6% | Added |
| Point72 Asset Management, L.P. | 167,204 | $3.72M | 0.01% | −97,111−36.7% | Reduced |
| Jump Financial, LLC | 172,747 | $3.84M | 0.03% | +160,947+1,364.0% | Added |
| BNP Paribas Arbitrage, SA | 199,429 | $4.43M | 0.00% | +170,805+596.7% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 217,157 | $4.83M | 0.01% | +48,106+28.5% | Added |
| Lord, Abbett & Co. LLC | 226,606 | $5.04M | 0.01% | +226,606 | New |
| Northern Trust Corp | 295,081 | $6.56M | 0.00% | +53,176+22.0% | Added |
| Vanguard Fiduciary Trust Co | 304,867 | $6.77M | 0.00% | +85,370+38.9% | Added |
| Millennium Management LLC | 314,548 | $6.99M | 0.00% | +154,497+96.5% | Added |
| Walleye Capital LLC | 365,272 | $8.12M | 0.04% | +365,272 | New |
| Ikarian Capital, LLC | 427,349 | $9.50M | 1.55% | −85,000−16.6% | Reduced |
| Blackstone Group Inc. | 435,320 | $9.67M | 0.03% | +435,320 | New |
| Vanguard Portfolio Management LLC | 461,528 | $10.3M | 0.00% | +250,209+118.4% | Added |
| Bank of America Corp | 486,955 | $10.8M | 0.00% | +448,357+1,161.6% | Added |
| Marshall Wace, LLP | 585,761 | $13.0M | 0.01% | −359,015−38.0% | Reduced |
| Standard Life Aberdeen plc | 621,108 | $13.8M | 0.02% | −246,176−28.4% | Reduced |
| Pictet Asset Management Holding SA | 733,768 | $16.3M | 0.02% | +733,768 | New |
| Goldman Sachs Group Inc | 735,224 | $16.3M | 0.00% | +582,187+380.4% | Added |
| Samsara BioCapital, LLC | 736,237 | $16.4M | 1.34% | −232,561−24.0% | Reduced |
| Affinity Asset Advisors, LLC | 840,350 | $18.7M | 0.91% | +200,394+31.3% | Added |
| Balyasny Asset Management LLC | 878,726 | $19.5M | 0.04% | +476,237+118.3% | Added |
| Foresite Capital Management VI LLC | 886,667 | $19.7M | 3.07% | +566,667+177.1% | Added |
| Citadel Advisors LLC | 929,407 | $20.7M | 0.01% | +792,185+577.3% | Added |
| Geode Capital Management, LLC | 985,178 | $21.9M | 0.00% | +162,658+19.8% | Added |
| Acorn Capital Advisors, LLC | 986,760 | $21.9M | 5.98% | +200,000+25.4% | Added |
| Versant Venture Management, LLC | 991,783 | $22.0M | 13.55% | −534,037−35.0% | Reduced |
| Logos Global Management LP | 1,125,000 | $25.0M | 1.08% | +725,000+181.3% | Added |
| Baker Bros. Advisors LP | 1,230,426 | $27.3M | 0.14% | −410,711−25.0% | Reduced |
| JPMorgan Chase & Co | 1,475,079 | $32.6M | 0.00% | +1,459,216+9,198.9% | Added |
| Soleus Capital Management, L.P. | 1,550,690 | $34.5M | 1.19% | +753,946+94.6% | Added |
| Remedium Capital Partners, LLC | 1,577,750 | $35.1M | 7.76% | 00.0% | Unchanged |
| Avidity Partners Management LP | 1,700,708 | $37.8M | 6.05% | +300,000+21.4% | Added |
| Polar Capital Holdings Plc | 1,846,982 | $41.0M | 0.12% | +1,846,982 | New |
| Adage Capital Partners GP, L.L.C. | 1,910,812 | $42.5M | 0.06% | +1,910,812 | New |
| Vanguard Capital Management LLC | 2,244,773 | $49.9M | 0.00% | +448,121+24.9% | Added |
| State Street Corp | 2,335,285 | $51.9M | 0.00% | +1,679,595+256.2% | Added |
| Franklin Resources Inc | 2,792,080 | $62.0M | 0.01% | +2,792,080 | New |
| BlackRock, Inc. | 2,801,451 | $62.2M | 0.00% | +487,502+21.1% | Added |
| Paradigm Biocapital Advisors LP | 2,857,405 | $63.5M | 1.19% | +2,857,405 | New |
| Bellevue Group AG | 3,057,996 | $67.9M | 1.43% | −443,506−12.7% | Reduced |
| VR Adviser, LLC | 3,220,364 | $71.6M | 2.17% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,671,083 | $81.6M | 0.71% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 4,553,494 | $101.2M | 6.69% | 00.0% | Unchanged |
| Jupiter Topco LLC | 6,273,262 | $139.4M | 0.06% | +6,273,262 | New |
| FMR LLC | 9,126,877 | $202.8M | 0.01% | +2,041,454+28.8% | Added |
| Great Point Partners LLC | 0 | $0 | 0.00% | −964,462−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −635,498−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −573,205−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −185,011−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −154,034−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −25,131−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −24,792−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −24,422−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −19,555−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −14,131−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −1,135−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |